TY - JOUR
T1 - Methods to control for unmeasured confounding in pharmacoepidemiology
T2 - an overview
AU - Uddin, Md Jamal
AU - Groenwold, Rolf H H
AU - Ali, Mohammed Sanni
AU - de Boer, Anthonius
AU - Roes, Kit C B
AU - Chowdhury, Muhammad A B
AU - Klungel, Olaf H.
PY - 2016/4/18
Y1 - 2016/4/18
N2 - Background Unmeasured confounding is one of the principal problems in pharmacoepidemiologic studies. Several methods have been proposed to detect or control for unmeasured confounding either at the study design phase or the data analysis phase. Aim of the Review To provide an overview of commonly used methods to detect or control for unmeasured confounding and to provide recommendations for proper application in pharmacoepidemiology. Methods/Results Methods to control for unmeasured confounding in the design phase of a study are case only designs (e.g., case-crossover, case-time control, self-controlled case series) and the prior event rate ratio adjustment method. Methods that can be applied in the data analysis phase include, negative control method, perturbation variable method, instrumental variable methods, sensitivity analysis, and ecological analysis. A separate group of methods are those in which additional information on confounders is collected from a substudy. The latter group includes external adjustment, propensity score calibration, two-stage sampling, and multiple imputation. Conclusion As the performance and application of the methods to handle unmeasured confounding may differ across studies and across databases, we stress the importance of using both statistical evidence and substantial clinical knowledge for interpretation of the study results.
AB - Background Unmeasured confounding is one of the principal problems in pharmacoepidemiologic studies. Several methods have been proposed to detect or control for unmeasured confounding either at the study design phase or the data analysis phase. Aim of the Review To provide an overview of commonly used methods to detect or control for unmeasured confounding and to provide recommendations for proper application in pharmacoepidemiology. Methods/Results Methods to control for unmeasured confounding in the design phase of a study are case only designs (e.g., case-crossover, case-time control, self-controlled case series) and the prior event rate ratio adjustment method. Methods that can be applied in the data analysis phase include, negative control method, perturbation variable method, instrumental variable methods, sensitivity analysis, and ecological analysis. A separate group of methods are those in which additional information on confounders is collected from a substudy. The latter group includes external adjustment, propensity score calibration, two-stage sampling, and multiple imputation. Conclusion As the performance and application of the methods to handle unmeasured confounding may differ across studies and across databases, we stress the importance of using both statistical evidence and substantial clinical knowledge for interpretation of the study results.
KW - Observational studies
KW - Pharmacoepidemiology
KW - Residual confounding
KW - Review
KW - Statistical methods
KW - Unmeasured confounding
KW - Unobserved confounding
UR - http://www.scopus.com/inward/record.url?scp=84964325837&partnerID=8YFLogxK
U2 - 10.1007/s11096-016-0299-0
DO - 10.1007/s11096-016-0299-0
M3 - Article
AN - SCOPUS:84964325837
SN - 2210-7703
VL - 38
SP - 714
EP - 723
JO - International Journal of Clinical Pharmacy
JF - International Journal of Clinical Pharmacy
IS - 3
ER -